PSI.TO vs. NVO
PSI.TO (Pason Systems Inc.) and NVO (Novo Nordisk A/S) are both stocks. PSI.TO operates in Oil & Gas Equipment & Services (Energy), while NVO operates in Drug Manufacturers - General (Healthcare). Over the past 10 years, PSI.TO returned 2.08%/yr vs 7.28%/yr for NVO. At a correlation of -0.00, they often move in opposite directions.
Performance
PSI.TO vs. NVO - Performance Comparison
Loading charts...
Different Trading Currencies
PSI.TO is traded in CAD, while NVO is traded in USD. To make them comparable, the NVO values have been converted to CAD using the latest available exchange rates.
Returns By Period
In the year-to-date period, PSI.TO achieves a 21.33% return, which is significantly higher than NVO's -11.24% return. Over the past 10 years, PSI.TO has underperformed NVO with an annualized return of 2.08%, while NVO has yielded a comparatively higher 7.28% annualized return.
PSI.TO
- 1D
- -1.10%
- 1M
- -4.19%
- YTD
- 21.33%
- 6M
- 20.26%
- 1Y
- 22.71%
- 3Y*
- 11.37%
- 5Y*
- 13.67%
- 10Y*
- 2.08%
NVO
- 1D
- -1.60%
- 1M
- -4.02%
- YTD
- -11.24%
- 6M
- -6.27%
- 1Y
- -36.91%
- 3Y*
- -15.64%
- 5Y*
- 6.38%
- 10Y*
- 7.28%
PSI.TO vs. NVO - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
PSI.TO Pason Systems Inc. | 21.33% | -8.11% | -12.20% | 6.85% | 43.65% | 50.72% | -35.32% | -25.04% | 4.25% | -3.83% |
NVO Novo Nordisk A/S | -11.24% | -42.01% | -8.71% | 51.43% | 31.40% | 62.04% | 21.25% | 22.38% | -5.60% | 43.18% |
Correlation
The correlation between PSI.TO and NVO is 0.04, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.04 |
Correlation (3Y) Calculated over the trailing 3-year period | -0.02 |
Correlation (5Y) Calculated over the trailing 5-year period | -0.02 |
Correlation (10Y) Calculated over the trailing 10-year period | -0.01 |
Correlation (All Time) Calculated using the full available price history since Jun 25, 2009 | -0.00 |
Fundamentals
PSI.TO:
CA$1.12B
NVO:
$191.12B
PSI.TO:
CA$0.59
NVO:
$27.42
PSI.TO:
24.35
NVO:
1.57
PSI.TO:
0.53
NVO:
0.07
PSI.TO:
2.75
NVO:
0.58
PSI.TO:
2.30
NVO:
0.94
PSI.TO:
CA$408.53M
NVO:
$327.80B
PSI.TO:
CA$177.97M
NVO:
$268.30B
PSI.TO:
CA$134.64M
NVO:
$181.54B
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
PSI.TO vs. NVO — Risk / Return Rank
PSI.TO
NVO
PSI.TO vs. NVO - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Pason Systems Inc. (PSI.TO) and Novo Nordisk A/S (NVO). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| PSI.TO | NVO | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +1.54 | ||
| Sortino ratioReturn per unit of downside risk | +2.20 | ||
| Omega ratioGain probability vs. loss probability | 1.17 | 0.89 | +0.28 |
| Calmar ratioReturn relative to maximum drawdown | 1.58 | -0.68 | +2.27 |
| Martin ratioReturn relative to average drawdown | 3.48 | -1.02 | +4.50 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| PSI.TO | NVO | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 0.82 | -0.72 | +1.54 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.42 | 0.17 | +0.25 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.06 | 0.23 | -0.17 |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.37 | 0.56 | -0.19 |
Drawdowns
PSI.TO vs. NVO - Drawdown Comparison
The maximum PSI.TO drawdown since its inception was -81.10%, which is greater than NVO's maximum drawdown of -74.27%. Use the drawdown chart below to compare losses from any high point for PSI.TO and NVO.
Loading charts...
Drawdown Indicators
| PSI.TO | NVO | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -81.10% | -74.27% | -6.83% |
Max Drawdown (1Y)Largest decline over 1 year | -14.04% | -54.08% | +40.04% |
Max Drawdown (3Y)Largest decline over 3 years | -40.01% | -74.27% | +34.26% |
Max Drawdown (5Y)Largest decline over 5 years | -40.01% | -74.27% | +34.26% |
Max Drawdown (10Y)Largest decline over 10 years | -74.78% | -74.27% | -0.51% |
Current DrawdownCurrent decline from peak | -32.73% | -68.14% | +35.41% |
Average DrawdownAverage peak-to-trough decline | -28.29% | -13.20% | -15.09% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 6.36% | 36.27% | -29.91% |
Volatility
PSI.TO vs. NVO - Volatility Comparison
Pason Systems Inc. (PSI.TO) and Novo Nordisk A/S (NVO) have volatilities of 8.29% and 8.48%, respectively, indicating that both stocks experience similar levels of price fluctuations. This suggests that the risk associated with both stocks, as measured by volatility, is nearly the same. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| PSI.TO | NVO | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 8.29% | 8.48% | -0.19% |
Volatility (6M)Calculated over the trailing 6-month period | 21.28% | 37.72% | -16.44% |
Volatility (1Y)Calculated over the trailing 1-year period | 27.10% | 51.30% | -24.20% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 32.50% | 37.82% | -5.32% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 34.27% | 32.11% | +2.16% |
Dividends
PSI.TO vs. NVO - Dividend Comparison
PSI.TO's dividend yield for the trailing twelve months is around 3.61%, less than NVO's 4.20% yield.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
NVO Novo Nordisk A/S | 4.20% | 3.31% | 1.68% | 1.00% | 1.20% | 1.35% | 1.87% | 2.14% | 1.45% | 1.52% | 2.87% | 0.92% |
PSI.TO Pason Systems Inc. | 3.61% | 4.34% | 4.44% | 4.20% | 3.54% | 2.35% | 7.00% | 5.64% | 3.83% | 3.74% | 3.46% | 3.51% |
Financials
PSI.TO vs. NVO - Financials Comparison
This section allows you to compare key financial metrics between Pason Systems Inc. and Novo Nordisk A/S. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
PSI.TO vs. NVO - Profitability Comparison
PSI.TO - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Pason Systems Inc. reported a gross profit of 45.49M and revenue of 102.44M. Therefore, the gross margin over that period was 44.4%.
NVO - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Novo Nordisk A/S reported a gross profit of 83.23B and revenue of 96.82B. Therefore, the gross margin over that period was 86.0%.
PSI.TO - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Pason Systems Inc. reported an operating income of 17.76M and revenue of 102.44M, resulting in an operating margin of 17.3%.
NVO - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Novo Nordisk A/S reported an operating income of 59.62B and revenue of 96.82B, resulting in an operating margin of 61.6%.
PSI.TO - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Pason Systems Inc. reported a net income of 13.04M and revenue of 102.44M, resulting in a net margin of 12.7%.
NVO - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Novo Nordisk A/S reported a net income of 48.56B and revenue of 96.82B, resulting in a net margin of 50.2%.
Frequently Asked Questions
PSI.TO and NVO have a correlation of 0.04, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
Find the right allocation for PSI.TO and NVO
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer